IL17C and neoplasm: In order to address whether IL-17C confers tumor-promoting activities in the in vivo model of colorectal cancer, DLD-1 cells were subcutaneously inoculated into the flanks of nude mice (n = 10 per group) and IL-17C (1 μg/tumor) was injected peritumorally for 10 days.